BridgeMD
SCARFREE-001: Verteporfin for Scar Prevention
EU CTIS ID: 2025-525083-14-00
What this study is testing
To evaluate the preliminary efficacy and dose–response of intradermal verteporfin for scar prevention following surgery.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Scheduled to undergo elective abdominoplasty amenable to primary closure
- Age ≥ 18 years old
- ASA class I–II
- Ability to provide written and informed consent and willing to comply with study procedures
- Fitzpatrick skin type I-IV
You likely can't join if
- Pregnancy or planned pregnancy within the next 6 months at the time of inclusion
- Autoimmune or fibrotic skin conditions
- Current use of photosensitizing medications
- Any medical condition deemed by the investigator to pose a risk to safety or data integrity
- Breastfeeding
- Smoking within the previous 6 months
See the full eligibility criteria
- Scheduled to undergo elective abdominoplasty amenable to primary closure
- Age ≥ 18 years old
- ASA class I–II
- Ability to provide written and informed consent and willing to comply with study procedures
- Fitzpatrick skin type I-IV
- Pregnancy or planned pregnancy within the next 6 months at the time of inclusion
- Autoimmune or fibrotic skin conditions
- Current use of photosensitizing medications
- Any medical condition deemed by the investigator to pose a risk to safety or data integrity
- Breastfeeding
- Smoking within the previous 6 months
- Excessive alcohol intake (>10 units/week for women, >14 units/week for men)
- Participants who are unable to read, understand and communicate in Danish sufficiently to provide informed consent and comply with study procedures
- Known conditions of pathological scarring or other conditions affecting wound healing
- Known hypersensitivity to verteporfin or any excipients
- Porphyria or other photosensitivity disorders
- Moderate hepatic dysfunction or biliary obstruction
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.